| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 01/20/2005 | US20050014705 E.g., dimethylcarbamic acid, 2-oxo-3-benzyl-4-methyl-2H-1-benzopyran; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 01/20/2005 | US20050014701 Synergistic mixture; anticoagulants |
| 01/20/2005 | US20050014695 Uses of a chemokine receptor able to bind to MCP-1, MIP-1 alpha and/or rantes |
| 01/20/2005 | US20050014222 Phosphatases which activate map kinase pathways |
| 01/20/2005 | CA2531629A1 Medicinal composition containing nf-.kappa.b decoy for treating and preventing respiratory diseases and method of using the same |
| 01/19/2005 | EP1498419A1 Process for preparing alkali metal salts of hydrophobic sulfonamides |
| 01/19/2005 | EP1498418A1 Sulfonamides for treatment of endothelin-mediated disorders |
| 01/19/2005 | EP1498145A1 DECOY FOR TREATING AND/OR PREVENTING Th2 CYTOKINE-ASSOCIATED ALLERGIC DISEASE, GATA3 MUTANT PROTEIN AND MEDICINAL COMPOSITIONS CONTAINING THE SAME |
| 01/19/2005 | EP1498137A1 Remedy for lung cancer |
| 01/19/2005 | EP1498132A1 Compositions for preventing or treating pollenosis, allergic nephritis, atopic dermatitits, asthma or urticaria |
| 01/19/2005 | EP1498130A1 Pharmaceutical composition of 4 herb extracts and method for its manufacture |
| 01/19/2005 | EP1498125A1 Use of compounds having ccr antagonism |
| 01/19/2005 | EP1498119A1 Use of conjugated linoleic acid for treating colds |
| 01/19/2005 | EP1497656A2 Diagnosis of carcinoma using raig1 polypeptides |
| 01/19/2005 | EP1497654A2 Immunoglobulin e vaccines and methods of use thereof |
| 01/19/2005 | EP1497294A1 1,2,3,4,7,8-HEXAHYDRO-6 i H /i - 1,4 DIAZEPINO 6,7 ,1- i 1J /i QUINOLINE DERIVATIVES AS ANTIPSYCHOTIC AND ANTI OBESITY AGENTS |
| 01/19/2005 | EP1497292A1 Azaindolylpiperidine derivatives as antihistaminic and antiallergic agents |
| 01/19/2005 | EP1497289A1 Medicaments containing betamimetic drugs and a novel anticholinesterase drug |
| 01/19/2005 | EP1497288A1 Novel ester hydroxy-substituted nitrogen heterocycles as antagonists of the muscarinic m3 receptor, methods for the production thereof, and use thereof as a medicament |
| 01/19/2005 | EP1497284A2 Pyrrolidinium derivatives as antagonists of m3 muscarinic receptors |
| 01/19/2005 | EP1497274A2 Terphenyl derivatives, preparation thereof, compositions containing same |
| 01/19/2005 | EP1497273A2 Hydroxamic acid derivatives |
| 01/19/2005 | EP1497268A2 Nitric oxide donors, compositions and methods of use |
| 01/19/2005 | EP1497261A1 Phenethanolamine derivatives |
| 01/19/2005 | EP1497256A1 Substituted 1,5-diaminopentan-3-ol compounds |
| 01/19/2005 | EP1497019A1 Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
| 01/19/2005 | EP1496940A2 Methods of treating diabetes using pde 11a inhibitors |
| 01/19/2005 | EP1496930A2 G-type peptides to ameliorate atherosclerosis |
| 01/19/2005 | EP1496929A1 Use of c5a receptor antagonist in the treatment of fibrosis |
| 01/19/2005 | EP1496921A1 Preparation containing a mixture of picrorrhiza and ginkgo for the relief of disease |
| 01/19/2005 | EP1496917A1 Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders |
| 01/19/2005 | EP1496914A1 (20S)-1a-HYDROXY-2a-METHYL AND 2&bgr;-METHYL-19-NOR-VITAM IN D sb 3 /sb AND THEIR USES |
| 01/19/2005 | EP1496910A1 Kinase inhibitors |
| 01/19/2005 | EP1496905A2 Modulators of hedgehog signaling pathways, compositions and uses related thereto |
| 01/19/2005 | EP1496902A1 Medicaments containing steroids and a novel anticholinesterase drug |
| 01/19/2005 | EP1496900A2 New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors |
| 01/19/2005 | EP1496892A2 1h-benzo(f)indazol-5-yl derivatives as selective glucocorticoid receptor modulators |
| 01/19/2005 | EP1496882A1 Tolterodine salts |
| 01/19/2005 | EP1496877A2 Method and composition for treatment of diabetes, hypertension, chronic heart failure and fluid retentive states |
| 01/19/2005 | EP1496876A2 Aerosol formulation for inhalation comprising a tiotropium salt |
| 01/19/2005 | EP1496873A2 Chewable soft capsule |
| 01/19/2005 | EP1496858A1 Inhalation kit comprisung inhalable powder of tiotropium |
| 01/19/2005 | EP1496857A1 Aerosol containing a particulate active substance |
| 01/19/2005 | EP1496838A2 Substituted amides |
| 01/19/2005 | EP1414475B1 An herbal composition for the treatment and remedy of bronchial respiratory difficulties |
| 01/19/2005 | EP1395574B1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 01/19/2005 | EP1377574B1 6-phenylbenzonaphthyridines |
| 01/19/2005 | EP1265615B1 Novel combination of non-sedative anti-histamines containing substances which influence the action of leukotriene, for treating rhinitis/conjunctivitis |
| 01/19/2005 | EP0831813B1 Methods of inhibiting pneumocystis carinii pneumonia and compounds useful therefor |
| 01/19/2005 | CN1568322A Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein junkinases |
| 01/19/2005 | CN1568321A Novel substituted 4-phenyl-4-ú¿1h-imidazol-2-ylú®-piperidine derivatives and their use as selective non-peptide delta opioid agonists |
| 01/19/2005 | CN1568320A 异羟肟酸衍生物 Hydroxamic acid derivatives |
| 01/19/2005 | CN1568207A 2-amino-6-(2, 4, 5-substituted-phenyl)-pyridines |
| 01/19/2005 | CN1566335A Mass preparation of SARS virus capable of meeting the production of inactivated vaccine and inactivation method |
| 01/19/2005 | CN1566334A Novel reovirus, its antibody and vaccine and use thereof |
| 01/19/2005 | CN1566330A Activated HLA semi-coincident allogene mixed hematopoietic stem cell and method for making same |
| 01/19/2005 | CN1566155A Anti-SARS monoclonal antibody, encoding sequence and application thereof |
| 01/19/2005 | CN1566144A Functional protein in SARS coronavirus |
| 01/19/2005 | CN1566143A Antigenic determinant of SARS coronavirus nucleocapsid protein and application thereof |
| 01/19/2005 | CN1566142A Polypeptide drug for inhibiting SARS coronavirus from infecting host cell |
| 01/19/2005 | CN1566140A Wan fritillaria extract, preparation method and uses thereof |
| 01/19/2005 | CN1566137A Production process for platycodin |
| 01/19/2005 | CN1566103A Moguisteine crystallographic form |
| 01/19/2005 | CN1566054A Resveratrol oligo cattail compounds, its manufacturing process, pharmaceutical combination and uses thereof |
| 01/19/2005 | CN1565631A Usage of fused protein of TNF receptor and globin in acute lung injury treating medicine |
| 01/19/2005 | CN1565628A Usage of reovirus genome and its coding protein in the SARS related research |
| 01/19/2005 | CN1565620A Usage of IL-1 acceptor antagon in the treatment of SARS |
| 01/19/2005 | CN1565613A Chinese medicinal composition for treating acute pharyngitis and gingivitis and preparing method thereof |
| 01/19/2005 | CN1565607A Chinese drug composition for treating viral infection of upper respiratory tract and preparing process thereof |
| 01/19/2005 | CN1565584A Preparing method of sugar free oral liquor |
| 01/19/2005 | CN1565581A Immune function regulating antibiotic and anti-inflammatory drug with broad spectrum |
| 01/19/2005 | CN1565578A Medicinal pills for treating enfant asthma |
| 01/19/2005 | CN1565572A SARS treating medicine |
| 01/19/2005 | CN1565569A Processing technique of Aconitum Carrnichaeli Debx |
| 01/19/2005 | CN1565559A Medicine for treating cold and cough |
| 01/19/2005 | CN1565558A Medicine for treating cough and profuse sputum |
| 01/19/2005 | CN1565537A Medicine for treating wind-warm lung-heat illness of children |
| 01/19/2005 | CN1565536A Cough stopping tablet of scutellariae and pig bile and its preparation method |
| 01/19/2005 | CN1565532A Preparing process of dripping pills for treating bronchitis |
| 01/19/2005 | CN1565525A Compound lozenge preparation of Chinese medicine and Western medicine and its preparation method |
| 01/19/2005 | CN1565521A Cold treating pills |
| 01/19/2005 | CN1565520A Nephritis treating medicinal capsule |
| 01/19/2005 | CN1565519A Chinese medicine buccal tablet and its preparing process |
| 01/19/2005 | CN1565512A Blood sugar decreasing Chinese herbal medicine for treating SARS patients with diabetes complication |
| 01/19/2005 | CN1565511A Chinese medicine oral liquid for preventing and treating virulent diarrhea due to the incursion of SARS virus to stomach and intestine |
| 01/19/2005 | CN1565510A Incense or incense holding box for preventing SARS and other epidemic disease |
| 01/19/2005 | CN1565503A Novel |
| 01/19/2005 | CN1565502A Novel formulation of 'GuiFu Dihuang' and its preparing method |
| 01/19/2005 | CN1565480A Externally used medicine for tracheitis and cough |
| 01/19/2005 | CN1565477A Iodine microsphere clathrate compound and its preparation method and uses |
| 01/19/2005 | CN1565447A Drug for prevention and cure of bacterial and viral infection , atypical pneumonia |
| 01/19/2005 | CN1565444A Ramatroban glue pill and its preparation method |
| 01/19/2005 | CN1565435A Nasal cavity nursing solution |
| 01/19/2005 | CN1565431A 3, 4-dihydroxylbenzaldehyde pharmaceutical use |
| 01/19/2005 | CN1185250C Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 01/19/2005 | CN1185233C Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
| 01/19/2005 | CN1185232C Inhibitors of alpha L beta 2 mediated cell adhesion |
| 01/19/2005 | CN1185229C 3-indolyl-4-phenyl-1H-pyrrole-2, 5-dione derivatives as inhibitors of glycogen synthase kinase-3beta |
| 01/19/2005 | CN1185227C Novel compounds |
| 01/19/2005 | CN1185226C Intermediate for preparing benzothiophene amide derivate |